Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Deka Biosciences
AddedFeb 17, 2024
UpdatedJun 18, 2026
Deka Biosciences

Deka Biosciences

Deka Biosciences: Pioneering next-gen targeted cytokine therapies for cancer and inflammatory diseases.

HQ
Germantown, MD, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Deka Biosciences, Inc. was founded with the mission to develop next-generation targeted cytokine therapies aimed at treating cancer and inflammatory diseases. The company focuses on creating innovative solutions to improve patient outcomes through its proprietary Diakine™ platform, which allows for the customization of cytokine treatments tailored to individual patient needs. Deka Biosciences operates in the biotechnology sector, specifically targeting the oncology and immunology markets.

Notable figures affiliated with Deka Biosciences include experienced scientists and industry veterans who bring a wealth of knowledge to the company's research and development efforts. The company has garnered attention from prominent investors in the biotech space, contributing to its rapid growth and development. Key achievements include advancing their pipeline of targeted cytokine therapies and making significant strides in preclinical studies. Deka Biosciences is poised to make a substantial impact on the treatment landscape for cancer and inflammatory diseases, offering hope for more effective and personalized therapies.

Deka Biosciences - Similar Companies

Synthekine logo

Synthekine

synthekine.com

DecImmune Therapeutics logo

DecImmune Therapeutics

decimmune.com

DeciBio Ventures logo

DeciBio Ventures

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

CytoAgents logo

CytoAgents

cytoagents.com

Ideaya Biosciences logo

Ideaya Biosciences

ideayabio.com

Incyclix Bio logo

Incyclix Bio

incyclixbio.com

Sudo Biosciences logo

Sudo Biosciences

sudobio.com

Vedanta Biosciences logo

Vedanta Biosciences

vedantabio.com

Lassen Therapeutics logo

Lassen Therapeutics

KeifeRx logo

KeifeRx

keiferx.com

HI-Bio logo

HI-Bio

hibio.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

Cadenza Bio logo

Cadenza Bio

cadenza.bio

Santa Ana Bio logo

Santa Ana Bio

santaanabio.com

Deka Biosciences - Quick Facts

Who are Deka Biosciences' competitors?

Companies similar to Deka Biosciences include Synthekine, DecImmune Therapeutics, DeciBio Ventures and Eikon Therapeutics.

When was Deka Biosciences founded?

Deka Biosciences was founded in 2018.

Where is Deka Biosciences' headquarters located?

Deka Biosciences' headquarters is located in Germantown, MD, US.

When was Deka Biosciences' last funding round?

Deka Biosciences' most recent funding round was for $29.9M (USD) in December 2023.

How much has Deka Biosciences raised to-date?

As of Dec 8, 2023, Deka Biosciences has raised a total of $91.4M (USD).

How many employees does Deka Biosciences have?

Deka Biosciences has 45 employees as of Feb 5, 2024.

Deka Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cytokine Therapies
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified